Supernus Pharmaceuticals, Inc. (SUPN)

Supernus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,663	1,581	1,928	1,551	1,326	1,244
Market Cap Growth	-5.23%	-18.00%	24.34%	16.99%	6.52%	-28.32%
Enterprise Value	1,398	1,359	1,905	1,632	1,293	1,273
PE Ratio	-	1201.42	31.76	29.03	10.44	11.01
PS Ratio	2.78	2.60	2.89	2.68	2.55	3.17
PB Ratio	1.79	1.72	2.18	1.90	1.78	2.09
P/FCF Ratio	16.66	14.30	16.56	12.40	9.84	8.78
P/OCF Ratio	16.57	14.23	16.51	12.20	9.58	8.69
EV/Sales Ratio	2.34	2.24	2.85	2.81	2.49	3.24
EV/EBITDA Ratio	17.50	15.10	12.42	12.63	6.14	7.20
EV/EBIT Ratio	-314.48	262.23	28.09	16.89	6.72	7.48
EV/FCF Ratio	14.00	12.30	16.36	13.04	9.60	8.98
Debt / Equity Ratio	0.04	0.04	0.49	0.52	0.52	0.63
Debt / EBITDA Ratio	0.41	0.37	2.86	3.26	1.85	2.12
Debt / FCF Ratio	0.33	0.30	3.76	3.36	2.90	2.65
Quick Ratio	1.42	1.38	0.91	1.55	2.30	2.71
Current Ratio	1.73	1.70	1.07	1.91	2.57	2.94
Asset Turnover	0.46	0.43	0.40	0.37	0.37	0.36
Interest Coverage	-5.60	2.15	9.59	4.12	8.10	7.50
Return on Equity (ROE)	-1.70%	0.10%	7.10%	6.70%	18.60%	21.00%
Return on Assets (ROA)	-1.20%	0.10%	3.60%	3.40%	8.90%	10.40%
Return on Capital (ROIC)	-1.68%	-0.34%	3.44%	4.69%	11.52%	11.73%
Earnings Yield	-0.93%	0.08%	3.15%	3.45%	9.58%	9.09%
FCF Yield	6.00%	6.99%	6.04%	8.07%	10.16%	11.39%
Buyback Yield / Dilution	10.93%	10.01%	-13.47%	-1.24%	0.24%	0.52%
Total Shareholder Return	10.93%	10.01%	-13.47%	-1.24%	0.24%	0.52%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).